Stem Cells Market Size to Hit USD 29.68 Bn by 2030

The global stem cells market was estimated at USD 12.53 billion in 2021 and it is projected to hit around USD 29.68 billion by 2030 poised to grow at a CAGR of 12.4% from 2022 to 2030.

The factors contributing to the growth include increasing demand for biologics, technological advancement in stem cell therapeutics, and a growing focus on the development of personalized medicines. The increasing focus on the treatment of neurological disorders contributes to the market expansion. According to the World Health Organization (WHO), around 7.1% of the total global burden of diseases is cerebrovascular diseases and neurological disorders. Hence, companies are conducting basic research and preclinical trials for testing the regenerative capacity of stem cells in the treatment of neurological conditions.

Get the sample copy of report@

For instance, in May 2020 Celavie Biosciences advanced its 5-year exploratory study on Parkinson’s disease. The company is developing regenerative stem cell therapies for treating central nervous system disorders and Parkinson’s disease. Celavie Biosciences released successful results for their exploratory clinical trials of OK99 stem cells for Parkinson’s disease.

Moreover, the gaining popularity of personalized medicines is further contributing to the market growth. Researchers are discovering new procurement methods that can be further applied for developing personalized medicines. For instance, iPSC therapies are developed using a small amount of sample from a patient’s blood or skin cell that is later reprogrammed to form new cells and tissue for transplant. Hence, with the application of these cells, potential personalized medicines can be developed.

Furthermore, Companies are focusing on developing therapies for reducing different stress associated with COVID-19. For instance, in October 2020, NoveCite and Novellus Therapeutics Limited entered into a partnership for developing & commercializing NoveCite iPSCs for treating COVID-19 associated Acute Respiratory Distress Syndrome (ARDS). The process has multimodal immunomodulatory mechanisms of action, which makes it a promising therapy for treating acute respiratory diseases.

Report Scope of the Stem Cells Market

Report Coverage


Market Size

US$ 29.68 Billion by 2030

Growth Rate

CAGR of 12.4% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year


Forecast Period

2022 to 2030

Segments Covered

Product, Source, Application, End-user and Region,

Companies Mentioned

 STEMCELL Technologies, Inc., Astellas Pharma, Inc., Cellular Engineering Technologies, Inc., BioTime, Inc., Takara Bio, Inc., U.S. Stem Cell, Inc., BrainStorm Cell Therapeutics, Inc., Cytori Therapeutics, Inc., Osiris Therapeutics, Inc., and Caladrius Biosciences, Inc.


Technological Advancements to Drive Market

Several companies are developing new approaches to culturing or utilizing stem cells for various applications. Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians, and offers hope of effective treatment for various malignant and non-malignant diseases. The stem cell technology is progressing as a result of multidisciplinary effort, and advances in this technology have stimulated a rapid growth in the understanding of embryonic and postnatal neural development.

Ask here for customization@

Adult Stem Cells Segment to Dominate Global Market

In terms of product type, the global stem cells market has been classified into adult stem cells, human embryonic stem cells, and induced pluripotent stem cells. The adult stem cells segment accounted for leading share of the global market in 2020. The capability of adult stem cells to generate a large number of specialized cells lowers the risk of rejection and enables repair of damaged tissues.

Autologous Segment to Lead Market

Based on source, the global stem cells market has been bifurcated into autologous and allogenic. The autologous segment accounted for leading share of the global market in 2020. Autologous stem cells are used from one’s own body to replace damaged bone marrow and hence it is safer and is commonly being practiced.

Regenerative Medicines to be Highly Lucrative

In terms of application, the global stem cells market has been categorized into regenerative medicines (neurology, oncology, cardiology, and others) and drug discovery & development. The regenerative medicines segment accounted for major share of the global market in 2020, as regenerative medicine is a stem cell therapy and the medicines are made using stem cells in order to repair an injured tissue. Increase in the number of cardiac diseases and other health conditions drive the segment.

Therapeutics Companies Emerge as Major End-users

Based on end-user, the global stem cells market has been divided into therapeutics companies, cell & tissue banks, tools & reagents companies, and service companies. The therapeutics companies segment dominated the global stem cells market in 2020. The segment is driven by increase in usage of stem cells to treat various illnesses in the body. Therapeutic companies are increasing the utilization of stem cells for providing various therapies. However, the cell & tissue banks segment is projected to expand at a high CAGR during the forecast period. Increase in number of banks that carry out research on stem cells required for tissue & cell growth and elaborative use of stem cells to grow various cells & tissues can be attributed to the growth of the segment.

Regional Insights

North America accounted for the largest market share of 52.1% in 2020; growth in the region can be attributed to several factors such as the presence of key players engaged in developing stem cell therapies, advanced healthcare infrastructure, extensive R&D, supportive reforms from healthcare organizations and strong reimbursement policies. The U.S. is the leading country in the region owing to government initiatives and high research activities in the country.

Healthcare organizations are promoting the use of cellular therapies for emerging diseases. For instance, in April 2020, the U.S. Food and Drug Administration (FDA) authorized a clinical trial exploratory efficacy study that used umbilical cord-derived MSCs for prevention of the life-threatening lung inflammation in COVID-19 patients.

Asia Pacific is expected to expand at the fastest CAGR of 9.0% during the forecast year owing to the increasing development of stem cell-based therapies, government initiatives for developing regenerative medicines, the setup of several stem cell banks, and increasing clinical trials for regenerative medicines in the region. For instance, in July 2020, MEDIPOST announced the results for NEUROSTEM’s phase 1/2a study. It is an investigational stem cell therapy that can be used for treating Alzheimer’s disease.

Some of the prominent players in the Stem Cells Market include:

  • STEMCELL Technologies, Inc.
  • Astellas Pharma, Inc.
  • Cellular Engineering Technologies, Inc.
  • BioTime, Inc.
  • Takara Bio, Inc.
  • U.S. Stem Cell, Inc.
  • BrainStorm Cell Therapeutics, Inc.
  • Cytori Therapeutics, Inc.
  • Osiris Therapeutics, Inc.
  • Caladrius Biosciences, Inc., among others

Market Segmentation

Stem Cells Market, by Product

  • Adult Stem Cell
  • Human Embryonic Stem Cell
  • Induced Pluripotent Stem Cell
  • Others

Stem Cells Market, by Source

  • Autologous
  • Allogenic

Stem Cells Market, by Application

  • Regenerative Medicines
    • Neurology
    • Oncology
    • Cardiology
    • Others
  • Drug Discovery & Development

Stem Cells Market, by End-user

  • Therapeutics Companies
  • Cell & Tissue Banks
  • Tools & Reagents Companies
  • Service Companies

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Click Here to View Full Report Table of Contents

Buy this Research Report@

You can place an order or ask any questions, please feel free to contact at | +1 9197 992 333

Back to news